← Back to home

NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT

Clinical trials for NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT explained in plain language.

Never miss a new study

Get alerted when new NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT trials appear

Sign up with your email to follow new studies for NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Hard-to-Treat cancers: adding a pill to standard chemo

Disease control Ongoing

This study is testing if adding a pill called venetoclax to standard chemotherapy works better than chemotherapy alone for people with aggressive types of B-cell lymphoma. The goal is to better control the cancer and keep it from coming back. About 363 adults with specific, hard-…

Matched conditions: NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT

Get alerted when new NEOPLASTIC CELLS WITH DOUBLE EXPRESSION OF MYC AND BCL2 PROTEINS PRESENT trials appear

New hope for Hard-to-Treat cancers: adding a pill to standard chemo